Making a Major Impact on B Cell Cancers
source: shutterstock.com

Making a Major Impact on B Cell Cancers

  Accutar Biotechnology, Cranbury, New Jersey recently announced via BioSpace that dosing has begun with the first patient enrolled in the Phase 1 trial of AC0676 a chimeric degrader molecule…

Continue Reading Making a Major Impact on B Cell Cancers
A New Treatment for Diffuse Large B-Cell Lymphoma Could be on its Way to EU Approval
source: shutterstock.com

A New Treatment for Diffuse Large B-Cell Lymphoma Could be on its Way to EU Approval

According to a story from Market Screener, the drug company AbbVie recently announced that its investigational therapy epcoritamab has received a positive opinion from the European Union's Committee for Medicinal…

Continue Reading A New Treatment for Diffuse Large B-Cell Lymphoma Could be on its Way to EU Approval
Rep. Jamie Raskin Shares Update on DLBCL, Says He is in Remission
https://pixabay.com/en/united-states-capitol-politics-1675539/

Rep. Jamie Raskin Shares Update on DLBCL, Says He is in Remission

In December 2022, Representative Jamie Raskin (D-MD) shared with the public that he had been diagnosed with diffuse large B-cell lymphoma (DLBCL). Although being diagnosed with cancer can be frightening,…

Continue Reading Rep. Jamie Raskin Shares Update on DLBCL, Says He is in Remission

Study: Diffuse Large B-Cell Lymphoma Patients May Benefit from Involvement in Decision Making

Due to varied periods of decline among patients, previous research indicates that it is difficult to develop treatment options for patients who have relapsed DLBCL. This holds true especially when…

Continue Reading Study: Diffuse Large B-Cell Lymphoma Patients May Benefit from Involvement in Decision Making
Diffuse Large B-Cell Lymphoma: Combination Treatment Superior to Systemic Therapy in Retrospective Study
source: unsplash.com

Diffuse Large B-Cell Lymphoma: Combination Treatment Superior to Systemic Therapy in Retrospective Study

According to a story from Cancer Network, the results of a recent retrospective study have found that a two-part combination treatment for diffuse large B-cell lymphoma (DLBCL), a rare cancer,…

Continue Reading Diffuse Large B-Cell Lymphoma: Combination Treatment Superior to Systemic Therapy in Retrospective Study
Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib
source: pixabay.com

Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib

According to a recent article, new evidence shows adding ibrutinib to a patient’s chemotherapy regimen may improve the longevity of younger patients with diffuse large B-cell lymphoma (DLBCL). Diffuse Large…

Continue Reading Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib
DPX Delivery Platform Could Improve Care For Many Rare Cancers
source: pixabay.com

DPX Delivery Platform Could Improve Care For Many Rare Cancers

IMV Inc. recently presented two posters at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics showcasing their DPX delivery platform's immunotherapeutic capabilities. IMV Inc. IMV Inc. is…

Continue Reading DPX Delivery Platform Could Improve Care For Many Rare Cancers

My Genetically Altered Life: How CAR-T Transformed My Life with Diffuse Large B-Cell Lymphoma

Written by Robyn Stacy-Humphries Wolverine, Spiderman, Wonder Woman, and Deadpool - superheroes most of us love. Why? They have superpowers and escape death by some type of genetic alteration. Humans…

Continue Reading My Genetically Altered Life: How CAR-T Transformed My Life with Diffuse Large B-Cell Lymphoma
Phase 2 Trial Results Show Loncastuximab Tesirine as Beneficial for DLBCL
biker_becca / Pixabay

Phase 2 Trial Results Show Loncastuximab Tesirine as Beneficial for DLBCL

In the Phase 2 LOTIS-2 clinical trial, researchers evaluated the safety, efficacy, and tolerability of Loncastuximab tesirine for patients with aggressive diffuse large B-cell lymphoma (DLBCL). While there are treatment…

Continue Reading Phase 2 Trial Results Show Loncastuximab Tesirine as Beneficial for DLBCL
Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients
source: pixabay.com

Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients

A Phase 3 clinical trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma in patients where it was previously untreated have just announced they are still recruiting participants. The trial is…

Continue Reading Phase 3 Trial for Non-Germinal Center Diffuse Large B-Cell Lymphoma is Still Enrolling Patients